CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Royalty Pharma to pay up to $425M for royalty interest in AstraZeneca’s cliramitug

cliramitugPositive
AI Analysis

Summary

Royalty Pharma announced a deal to acquire royalty interest in AstraZeneca's cliramitug for up to $425 million, expanding its royalty portfolio.

Importance:6/10
Sentiment:
0.30
royalty_dealacquisitionpartnership
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on July 22, 2026 11:47 AM

Read Original